Secretome-derived isotope tags (SDIT) reveal adipocyte-derived apolipoprotein C-I as a predictive marker for cardiovascular disease

Journal of Proteome Research

Volumn 11, Issue 5, 2012, Pages 2851-2862

  Li, Rong Xia ^a   Ding, Yu Bo ^a   Zhao, Shi Lin ^a   Xiao, Yuan Yuan ^a   Li, Qing Run ^a   Xia, Fang Ying ^a   Sun, Liang ^b   Lin, Xu ^b   Wu, Jia Rui ^a   Liao, Kan ^a   Zeng, Rong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

adipocyte secreted proteins; apolipoprotein C I; cardiovascular risk factors; obesity; secretome derived isotope tags

Indexed keywords

APOLIPOPROTEIN C1; BIOLOGICAL MARKER; ISOTOPE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN C-I; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; DIET, HIGH-FAT; FEMALE; GOLGI APPARATUS; HUMANS; HYPERTRIGLYCERIDEMIA; ISOTOPE LABELING; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; ODDS RATIO; PRIMARY CELL CULTURE; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS;

MURINAE; MUS; RATTUS;

EID: 84860617183     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201224e     Document Type: Article

References (46)

1. Wang, P.; Mariman, E.; Keijer, J.; Bouwman, F.; Noben, J. P.; Robben, J.; Renes, J. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines Cell. Mol. Life Sci. 2004, 61 (18) 2405-17
2. Hauner, H. Secretory factors from human adipose tissue and their functional role Proc. Nutr. Soc. 2005, 64 (2) 163-9
3. Fantuzzi, G. Adipose tissue, adipokines, and inflammation J. Allergy Clin. Immunol. 2005, 115 (5) 911-9
4. Schaffler, A.; Scholmerich, J.; Buchler, C. Mechanisms of disease: adipocytokines and visceral adipose tissue - emerging role in intestinal and mesenteric diseases Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2 (2) 103-11
5. Romijn, E. P.; Christis, C.; Wieffer, M.; Gouw, J. W.; Fullaondo, A.; van der Sluijs, P.; Braakman, I.; Heck, A. J. Expression clustering reveals detailed co-expression patterns of functionally related proteins during B cell differentiation: a proteomic study using a combination of one-dimensional gel electrophoresis, LC-MS/MS, and stable isotope labeling by amino acids in cell culture (SILAC) Mol. Cell. Proteomics 2005, 4 (9) 1297-310
6. Mannova, P.; Fang, R.; Wang, H.; Deng, B.; McIntosh, M. W.; Hanash, S. M.; Beretta, L. Modification of host lipid raft proteome upon hepatitis C virus replication Mol. Cell. Proteomics 2006, 5 (12) 2319-25
7. Geiger, T.; Cox, J.; Ostasiewicz, P.; Wisniewski, J. R.; Mann, M. Super-SILAC mix for quantitative proteomics of human tumor tissue Nat. Methods 2010, 7 (5) 383-5
8. Yuan, T.; Hong, S.; Yao, Y.; Liao, K. Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes Cell Res. 2007, 17 (9) 772-82
9. Huo, H.; Guo, X.; Hong, S.; Jiang, M.; Liu, X.; Liao, K. Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction J. Biol. Chem. 2003, 278 (13) 11561-9
10. Tang, L. Y.; Deng, N.; Wang, L. S.; Dai, J.; Wang, Z. L.; Jiang, X. S.; Li, S. J.; Li, L.; Sheng, Q. H.; Wu, D. Q.; Li, L.; Zeng, R. Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction Mol. Cell. Proteomics 2007, 6 (11) 1952-67
11. Wu, Y. B.; Dai, J.; Yang, X. L.; Li, S. J.; Zhao, S. L.; Sheng, Q. H.; Tang, J. S.; Zheng, G. Y.; Li, Y. X.; Wu, J. R.; Zeng, R. Concurrent quantification of proteome and phosphoproteome to reveal system-wide association of protein phosphorylation and gene expression Mol. Cell. Proteomics 2009, 8 (12) 2809-26
12. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4 (3) 207-14
13. Park, S. K.; Venable, J. D.; Xu, T.; Yates, J. R., 3rd A quantitative analysis software tool for mass spectrometry-based proteomics Nat. Methods 2008, 5 (4) 319-22
14. Hoaglin, D. C.; Mosteller, F.; Tukey, J. W. Understanding Robust and Exploratory Data Analysis; Wiley: New York, 2000; p 447.
15. Kim, K. Y.; Kim, B. J.; Yi, G. S. Reuse of imputed data in microarray analysis increases imputation efficiency BMC Bioinf. 2004, 5, 160
16. Sun, L.; Yu, Z.; Ye, X.; Zou, S.; Li, H.; Yu, D.; Wu, H.; Chen, Y.; Dore, J.; Clement, K.; Hu, F. B.; Lin, X. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese Diabetes Care 2010, 33 (9) 1925-32
17. Li, R. X.; Chen, H. B.; Tu, K.; Zhao, S. L.; Zhou, H.; Li, S. J.; Dai, J.; Li, Q. R.; Nie, S.; Li, Y. X.; Jia, W. P.; Zeng, R.; Wu, J. R. Localized-statistical quantification of human serum proteome associated with type 2 diabetes PLoS One 2008, 3 (9) e3224
18. Grundy, S. M.; Brewer, H. B., Jr.; Cleeman, J. I.; Smith, S. C., Jr.; Lenfant, C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 2004, 109 (3) 433-8
19. Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; Gordon, D. J.; Krauss, R. M.; Savage, P. J.; Smith, S. C., Jr.; Spertus, J. A.; Costa, F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 2005, 112 (17) 2735-52
20. Callister, S. J.; Barry, R. C.; Adkins, J. N.; Johnson, E. T.; Qian, W. J.; Webb-Robertson, B. J.; Smith, R. D.; Lipton, M. S. Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics J. Proteome Res. 2006, 5 (2) 277-86
21. Sun, L.; Yu, Z.; Ye, X.; Zou, S.; Li, H.; Yu, D.; Wu, H.; Chen, Y.; Dore, J.; Clement, K.; Hu, F. B.; Lin, X. A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese Diabetes Care 2010, 33 (9) 1925-32
22. Raab, R. M.; Bullen, J.; Kelleher, J.; Mantzoros, C.; Stephanopoulos, G. Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction Nutr. Metab. 2005, 2, 15
23. Lin, S.; Thomas, T. C.; Storlien, L. H.; Huang, X. F. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice Int J. Obes. Relat. Metab. Disord. 2000, 24 (5) 639-46
24. Jin, J.; Davis, J.; Zhu, D.; Kashima, D. T.; Leroueil, M.; Pan, C.; Montine, K. S.; Zhang, J. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells BMC Neurosci. 2007, 8, 67
25. Tonshoff, B.; Blum, W. F.; Vickers, M.; Kurilenko, S.; Mehls, O.; Ritz, E. Quantification of urinary insulin-like growth factors (IGFs) and IGF binding protein 3 in healthy volunteers before and after stimulation with recombinant human growth hormone Eur. J. Endocrinol. 1995, 132 (4) 433-7
26. Meier, C. A.; Thalmann, S. White adipose tissue, inflammation and atherosclerosis Bull. Acad. Natl. Med. 2007, 191 (4-5) 897-910
27. Owan, T.; Litwin, S. E. Is there a cardiomyopathy of obesity? Curr. Heart Failure Rep. 2007, 4 (4) 221-8
28. Selwyn, A. P. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update Am. J. Cardiol. 2007, 100 (12A) 33P-37P
29. Ahima, R. S.; Flier, J. S. Adipose tissue as an endocrine organ Trends Endocrinol. Metab. 2000, 11 (8) 327-32
30. Costa, J. V.; Duarte, J. S. Adipose tissue and adipokines Acta Med. Port. 2006, 19 (3) 251-6
31. Ingalls, A. M.; Dickie, M. M.; Snell, G. D. Obese, a new mutation in the house mouse J. Hered. 1950, 41 (12) 317-8
32. Vaisar, T.; Pennathur, S.; Green, P. S.; Gharib, S. A.; Hoofnagle, A. N.; Cheung, M. C.; Byun, J.; Vuletic, S.; Kassim, S.; Singh, P.; Chea, H.; Knopp, R. H.; Brunzell, J.; Geary, R.; Chait, A.; Zhao, X. Q.; Elkon, K.; Marcovina, S.; Ridker, P.; Oram, J. F.; Heinecke, J. W. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL J. Clin. Invest. 2007, 117 (3) 746-56
33. Soutar, A. K.; Garner, C. W.; Baker, H. N.; Sparrow, J. T.; Jackson, R. L.; Gotto, A. M.; Smith, L. C. Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase Biochemistry 1975, 14 (14) 3057-64
34. Gautier, T.; Masson, D.; de Barros, J. P.; Athias, A.; Gambert, P.; Aunis, D.; Metz-Boutigue, M. H.; Lagrost, L. Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity J. Biol. Chem. 2000, 275 (48) 37504-9
35. Dumont, L.; Gautier, T.; de Barros, J. P.; Laplanche, H.; Blache, D.; Ducoroy, P.; Fruchart, J.; Fruchart, J. C.; Gambert, P.; Masson, D.; Lagrost, L. Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI J. Biol. Chem. 2005, 280 (45) 38108-16
36. Simonet, W. S.; Bucay, N.; Pitas, R. E.; Lauer, S. J.; Taylor, J. M. Multiple tissue-specific elements control the apolipoprotein E/C-I gene locus in transgenic mice J. Biol. Chem. 1991, 266 (14) 8651-4
37. Conde-Knape, K.; Bensadoun, A.; Sobel, J. H.; Cohn, J. S.; Shachter, N. S. Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase J. Lipid Res. 2002, 43 (12) 2136-45
38. Olsson, B.; Gigante, B.; Mehlig, K.; Bergsten, A.; Leander, K.; de Faire, U.; Lissner, L.; Thelle, D. S.; Carlsson, L. M. Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease Metabolism 2010, 59 (12) 1734-41
39. Muurling, M.; van den Hoek, A. M.; Mensink, R. P.; Pijl, H.; Romijn, J. A.; Havekes, L. M.; Voshol, P. J. Overexpression of APOC1 in obob mice leads to hepatic steatosis and severe hepatic insulin resistance J. Lipid Res. 2004, 45 (1) 9-16
40. Berbee, J. F.; van der Hoogt, C. C.; Sundararaman, D.; Havekes, L. M.; Rensen, P. C. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL J. Lipid Res. 2005, 46 (2) 297-306
41. Xu, Y.; Berglund, L.; Ramakrishnan, R.; Mayeux, R.; Ngai, C.; Holleran, S.; Tycko, B.; Leff, T.; Shachter, N. S. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E J. Lipid Res. 1999, 40 (1) 50-8
42. Hubacek, J. A.; Pitha, J.; Adamkova, V.; Skodova, Z.; Lanska, V.; Poledne, R. Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms Physiol. Res. 2003, 52 (2) 195-200
43. Anuurad, E.; Yamasaki, M.; Shachter, N.; Pearson, T. A.; Berglund, L. ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans J. Lipid Res. 2009, 50 (7) 1472-8
44. Cohn, J. S.; Tremblay, M.; Batal, R.; Jacques, H.; Veilleux, L.; Rodriguez, C.; Bernier, L.; Mamer, O.; Davignon, J. Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects J. Lipid Res. 2002, 43 (10) 1680-7
45. Bjorkegren, J.; Silveira, A.; Boquist, S.; Tang, R.; Karpe, F.; Bond, M. G.; de Faire, U.; Hamsten, A. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis Arterioscler., Thromb., Vasc. Biol. 2002, 22 (9) 1470-4
46. van der Ham, R. L.; Alizadeh Dehnavi, R.; Berbee, J. F.; Putter, H.; de Roos, A.; Romijn, J. A.; Rensen, P. C.; Tamsma, J. T. Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome Diabetes Care 2009, 32 (1) 184-6